Missing the Mark: Hepatic Encephalopathy journal supplement: Hepatic Encephalopathy and Strategies to Prevent Readmission from Inadequate Transitions of Care
.jpg?sv=2018-03-28&sr=c&sig=5QVvIwuBif1gyejGX4t2xfv6vs%2FRSSYG8GK6cG8f5fE%3D&st=2026-04-04T05%3A02%3A02Z&se=2026-04-04T09%3A07%3A02Z&sp=r)
Overview
This article is one of six invited review articles published in the Missing the Mark: Hepatic Encephalopathy supplement, which includes CME-accredited articles published in Clinical Gastroenterology and Hepatology (CGH) and the Journal of Hospital Medicine (JHM). The program is administered by AGA in collaboration with the Society of Hospital Medicine. Each article will provide an expert perspective on a topic related to practice gaps in the care and management of patients with cirrhosis and hepatic encephalopathy. This program is commercially supported by Salix.
Learning objectives
Upon completion of this CME exam, successful learners will be able to identify established and novel treatment modalities for hepatic encephalopathy.
Key dates
- Released date:
- Jun 11, 2022
- Expiration date:
- May 31, 2026
Sponsor
This paper is part of a supplement supported by an independent educational grant from Salix Pharmaceuticals, a division of Bausch Health US, LLC. Salix Pharmaceuticals had no involvement in the creation of the content, including author selection, manuscript development or peer review. The views and opinions expressed in the articles are those of the authors
Agenda
All times are Eastern.
Session Heading 1: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Session Heading 2: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Course contents
Welcome | Hepatic Encephalopathy journal supplement: Hepatic Encephalopathy and Strategies to Prevent Readmission from Inadequate Transitions of Care
Manuscript | Hepatic Encephalopathy journal supplement: Hepatic Encephalopathy and Strategies to Prevent Readmission from Inadequate Transitions of Care
Evaluation
Course faculty and disclosures
Faculty
Robert S. Rahimi, MD, MSCR
Baylor University Medical Center, Baylor Scott & White Health, Dallas, TX
Mohammad Amin Fallahzadeh, MD, MPH
Baylor University Medical Center, Baylor Scott & White Health, Dallas, TX
Credit information
- CME Expiration Date:
- May 31, 2026
Accreditation and designation statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AGA Institute designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and mitigate all conflicts of interest prior to delivering the educational activity to learners.